Episode 11. ASH22 Recap: Lymphoma and CLL
Blood Cancer Talks
00:00
The Safety of Abrutnyb in Cardiovascular Disease
Abrutnyb is probably the safest drug overall other than atrial fibrillation which I think is an abrutnyb wins with across the board if you look at all the studies that have been done. So really from a safety point of view they've really only got that cardiac arrhythmia a safety profile as the advantage. But to be honest A.K.A.L.A. has a slight advantage in that certainly a lot of Europe and the US have used a lot more A.k.A. Calabruchnib over the last say five years or so.
Transcript
Play full episode
